SEC Comment Letter for Century Therapeutics, (IPSC) — Feb 17, 2026
Century Therapeutics, Inc.
Date: Feb. 17, 2026 · CIK: 0001850119 · Accession: 0000000000-26-001611
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-293228
Letter
Re: Century Therapeutics, Inc. Registration Statement on Form S-3 Filed February 05, 2026 File No. 333-293228 Dear Brent Pfeiffenberger:
February 17, 2026
Brent Pfeiffenberger Chief Executive Officer Century Therapeutics, Inc. 25 North 38th Street, 11th Floor Philadelphia, PA 19104
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Lauren Hamill at 303-844-1008 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Jennifer Porter
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> February 17, 2026 Brent Pfeiffenberger Chief Executive Officer Century Therapeutics, Inc. 25 North 38th Street, 11th Floor Philadelphia, PA 19104 Re: Century Therapeutics, Inc. Registration Statement on Form S-3 Filed February 05, 2026 File No. 333-293228 Dear Brent Pfeiffenberger: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Lauren Hamill at 303-844-1008 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Jennifer Porter </TEXT> </DOCUMENT>